Ghost Proteins” May Unlock the Mystery of Long COVID
Researchers may have identified a crucial piece of the puzzle behind long COVID — the lingering symptoms that affect millions worldwide months after infection. A groundbreaking study has detected 65 fragments of the SARS-CoV-2 protein Pp1ab hidden inside extracellular vesicles (EVs) in blood samples of long COVID patients (TGen, 2025). These protein remnants, dubbed “ghost proteins,” may explain why some people continue to experience fatigue, brain fog, and breathing difficulties long after recovering from the acute infection.
What Are “Ghost Proteins”?
Ghost proteins are viral protein fragments — not live virus — trapped inside EVs, which are tiny, naturally occurring particles that transport proteins and genetic material between cells (Lundquist Institute, 2025). The identified fragments come from Pp1ab, a large polyprotein critical for viral replication. Importantly, these ghost proteins were absent in pre-pandemic control samples, making them a strong candidate as a measurable biomarker for long COVID (TGen, 2025).
How the Study Was Conducted
The research team from the Translational Genomics Research Institute (TGen) and Lundquist Institute collected blood samples from long COVID patients, isolated EVs, and performed advanced proteomic analysis to search for viral signatures (Lundquist Institute, 2025).
-
65 unique fragments were detected, all originating from Pp1ab.
-
These were found across multiple samples, although not consistently at every time point.
-
No large viral proteins — which would indicate ongoing viral replication — were detected, raising questions about whether these fragments come from a hidden viral reservoir or are simply long-lasting debris from the initial infection (TGen, 2025).
Why This Matters
1. A Potential Biomarker for Long COVID
Doctors currently diagnose long COVID largely by exclusion — based on symptoms that persist for 12 weeks or more after infection. A measurable biomarker could objectively confirm diagnosis and allow for earlier intervention (TGen, 2025).
2. Insight Into Persistent Symptoms
Ghost proteins may continue to trigger immune responses or inflammation even in the absence of active virus, potentially explaining why patients experience symptoms like chronic fatigue, cognitive impairment, and shortness of breath (SciTechDaily, 2025).
3. New Therapeutic Pathways
If these proteins are proven to drive symptoms, targeted therapies could be developed to clear them from the body — for example, by enhancing immune clearance or using novel biological filters (Lundquist Institute, 2025).
Key Challenges and Open Questions
Despite its promise, the discovery raises new questions:
-
Consistency of detection — not all samples showed ghost proteins, which could make testing timing-dependent (TGen, 2025).
-
Source of the fragments — researchers are still investigating whether these proteins represent persistent viral replication in hidden tissue reservoirs or are merely “molecular trash” that lingers in circulation (TGen, 2025).
-
Correlation with symptom severity — larger, controlled studies are needed to confirm whether patients with more ghost proteins have worse symptoms, or whether some asymptomatic people may also carry these remnants (Lundquist Institute, 2025).
A Major Step Forward
While many mysteries about long COVID remain, the identification of ghost proteins represents a major step toward understanding the condition. For the first time, scientists may have a biological signal to track long COVID, turning a subjective diagnosis into a measurable one.
This discovery opens the door to:
-
More precise testing — confirming long COVID with a blood test rather than symptom reports.
-
Personalized treatment plans — developing therapies that specifically target viral remnants.
-
Better patient care — validating patient experiences and providing clearer recovery timelines.
As one of the study’s lead authors stated, “Detecting these proteins gives us a window into what might be perpetuating symptoms — and a potential path to treatment.”
Conclusion
Ghost proteins could be the missing link explaining why some patients suffer for months or even years after COVID-19. Although further research is needed to confirm their exact role and develop targeted treatments, this finding offers hope for millions seeking answers.
With larger studies underway, doctors may soon have a diagnostic tool that can confirm long COVID objectively — and ultimately lead to more effective therapies.
Disclaimer
This article is for educational and informational purposes only. It does not provide medical advice or replace consultation with a qualified healthcare professional. If you are experiencing persistent symptoms after COVID-19, seek medical evaluation.
References
-
TGen (2025). Possible Long COVID Biomarker: Identification of SARS-CoV-2 Related Proteins in Serum Extracellular Vesicles. Translational Genomics Research Institute.
-
Lundquist Institute (2025). Research Findings on SARS-CoV-2 Protein Fragments in Long COVID Patients.
-
SciTechDaily (2025). Scientists Detect “Ghost Proteins” That Could Explain Long COVID.